RxSight Inc (RXST)
62.84
+1.16
(+1.88%)
USD |
NASDAQ |
May 06, 16:00
62.84
0.00 (0.00%)
After-Hours: 19:28
RxSight Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.1246 |
| March 31, 2023 | 0.278 |
| December 31, 2022 | 0.4468 |
| September 30, 2022 | 0.4171 |
| June 30, 2022 | 0.3626 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.3239 |
| December 31, 2021 | 0.2876 |
| September 30, 2021 | 0.2627 |
| June 30, 2021 | -0.1261 |
| March 31, 2021 | -0.0976 |
| December 31, 2020 | -0.082 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.1261
Minimum
Jun 2021
0.4468
Maximum
Dec 2022
0.169
Average
0.2627
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.3803 |
| Alphatec Holdings Inc | 6.565 |
| AtriCure Inc | 0.1356 |
| Intuitive Surgical Inc | 0.00 |
| iRhythm Technologies Inc | 0.1664 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 182.55M |
| Total Liabilities (Quarterly) | 22.19M |
| Shareholders Equity (Quarterly) | 160.36M |
| Current Ratio | 8.057 |
| Net Debt Paydown Yield | 0.55% |